PATENT CLAIM ANALYSIS

Application Number: 16353680
Application Type: Utility
Filing Date: 2019-03
Publication Date: 2019-07
Patent Classification: ["424", "093210"]

Abstract:
An isolated muscle progenitor cell being MyoD positive, CD34 negative and CD45 negative is disclosed. The muscle progenitor cell is genetically modified to express at least one neurotrophic factor. In addition, cell populations are disclosed, comprising at least four subpopulations of muscle cells each being genetically modified to express a different neurotrophic factor, wherein said neurotrophic factor is selected from the group consisting of glial derived neurotrophic factor (GDNF), insulin growth factor (IGF-1), vascular endothelial growth factor (VEGF) and brain-derived neurotrophic factor (BDNF). Uses of the cell populations are also disclosed.

Claim (Index 30):
The isolated cell population of  claim 27 , wherein each of said at least four subpopulations is genetically modified to express a single neurotrophic factor.

Metadata:
- Claim Count in Document: 11.0
- Percentile: 99.0
- Lexical Diversity: 1.81667
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14002782', '14556281', '15261959', '14359623', '12994761']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.759399712137595
- 35 USC 102 Novelty (BERT): 0.6136816228821432
- Combined Prediction Score: 0.7448279032120498
- Mean Citation Score: 379.966308
- Max Citation Score: 654.7633
- Similarity Product: 466.4526069323837

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test